drugset
drugset / Trial / NCT02273440

Effect of BIIL 284 BS on the Pharmacokinetics of Theophylline in Healthy Male Volunteers

NCT02273440 ↗

Phase 1 Completed 16 enrolled Boehringer Ingelheim
RandomizedCrossoverDouble-blindTreatment

Summary

To evaluate the effect of multiple doses of BIIL 284 BS on the pharmacokinetics of a single dose of theophylline.

Timeline

Start
2000-05
Primary completion
2000-07
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject AMELUBANT Small molecule — —
Subject Theophylline Small molecule — —

Indications

No indication recorded.